Anacor (ANAC) Approves 3.25M Common Offering

Anacor Pharmaceuticals (Nasdaq: ANAC), today announced the sale of 3.25 million shares of its common stock for gross proceeds of $21,450,000 pursuant to an underwriting agreement with Canaccord Genuity acting as the sole bookrunner. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 487,500 shares of common stock to cover over-allotments, if any.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Denarius Metals acquires 15% stake in Copper Giant, Trafigura invests
• Oruka Therapeutics (ORKA) files $1B mixed shelf
• Applied Optoelectronics sets up $600M at-the-market stock offering